PATENT CLAIM ANALYSIS

Application Number: 15912370
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "316000"]

Abstract:
Provided are methods for delaying or preventing onset of progressive memory decline by administering a muscarinic M2 receptor blocking compound to patients identified as at risk of developing a condition characterized by progressive memory decline, prior to onset of the condition.

Claim (Index 16):
The method of  claim 14 , wherein the condition characterized by progressive memory decline is dementia.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.30303
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13213960', '12080756', '14384641', '14114646', '11354576']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7644724274077813
- 35 USC 102 Novelty (BERT): 0.5017416630979551
- Combined Prediction Score: 0.7381993509767988
- Mean Citation Score: 223.943288
- Max Citation Score: 238.06194
- Similarity Product: 165.88275017435075

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test